Best Tennis Elbow Braces (Counterforce Brace): What the Research Actually Supports (and What It Doesn’t)
Key Takeaways: Best Tennis Elbow Braces
- The best tennis elbow braces are best viewed as supportive tools rather than replacements for physiotherapy or rehabilitation.
- Counterforce braces may help reduce symptoms for some people, but the research is mixed and generally applies to brace categories rather than specific commercial products.
- A placebo-controlled trial found benefits for some pain and function outcomes, although the study was small and its primary outcome did not show a significant between-group difference.
- Age-related findings are interesting but uncertain: they come from trial-level subgroup analyses based on participants’ mean age, not from a validated cutoff for individual patients.
- In my clinical experience, braces can be useful when patients want to stay active or keep working, but I would be cautious about relying on the brace alone while the underlying loading problem remains unaddressed.
- For longer-standing symptoms, the duration of the problem should be considered separately from age; current evidence does not support assuming that a brace becomes ineffective simply because tennis elbow has become chronic.
Introduction: Best Tennis Elbow Braces
Tennis elbow is a familiar problem in clinical practice. When I see it, the patient often has a job or daily routine that involves repeated use of the hands and forearms — for example, cabin crew, nurses, construction workers, or sometimes people who spend long hours working at a computer. The exact pattern varies, but repetitive loading is often part of the story.
Physiotherapy is usually an important part of managing lateral epicondylitis, but patients also regularly ask me about counterforce braces — the strap-and-pad devices worn just below the elbow — and some tell me they feel noticeably better when using one. I see braces as a possible adjunct rather than a replacement for rehabilitation. The more useful question is not whether someone can feel better wearing a brace, but how well that effect holds up when the device is actually studied.
Finding the best tennis elbow brace therefore isn’t as simple as comparing star ratings. Counterforce braces are widely used, but widespread use and strong evidence are not the same thing. The research is also more nuanced than a simple “works” or “doesn’t work” answer, particularly when age-related subgroup findings are considered. Below, I separate the options by the strength of the evidence behind the brace category, while keeping in mind that the studies generally evaluate types of braces rather than the specific commercial products sold today.
Some of the links on this site are affiliate links. If you purchase a product through these links, I may earn a commission. This doesn’t cost you anything, but it helps me maintain this page so I can continue to share free information with the world. As an Amazon Associate, I earn from qualifying purchases. Product links are provided for informational and convenience purposes only. Their inclusion does not constitute medical or nutritional advice or a personalized recommendation.
Best Tennis Elbow Brace for Short-Term Pain Relief After a Fresh Diagnosis: Mueller Hg80 Premium Tennis Elbow Support
Mueller Hg80 Premium Tennis Elbow Support — this is our overall pick for the best tennis elbow brace to try for short-term relief. The evidence behind it is category-level, not product-specific: placebo-controlled trials have tested counterforce braces broadly (including a counterforce sleeve and band, not just straps), not this particular product.
| Pros | Cons |
|---|---|
| Comfort is praised in several accessible reviews | Some reviewers report slipping or fastening issues |
| Adjustable pull-pocket strap lets you set and re-set tension without removing the brace | Study: A brace’s tension level measurably changes wrist proprioception and the pain threshold to passive stretching[1] — the same study also tested isokinetic wrist-extensor strength and reflex latency and found no significant tension-related effect on either, and it only measured these immediate, single-session outcomes, not real-world pain relief over time |
| Fits either arm; sized S/M and L/XL | Study: Not shown to outperform physiotherapy over the longer term[2] |
| Study: The general category of counterforce brace tested against a sham brace in the longitudinal placebo-controlled trial discussed below is the same category this product belongs to[3] — the trial’s public abstract doesn’t specify the exact pad/strap design used, so this is a category-level match, not a confirmed product-level one | Limited independent Amazon review volume compared to some competitors |
What buyers say about the Mueller Hg80 Premium Tennis Elbow Support: Reviews for this brace, pulled from Walmart’s marketplace listing and Mueller’s own retail partners, skew positive overall, with comfort a recurring theme in several accessible reviews. Some reviewers report the strap slipping or fastening issues; at least one review describes the “comfortable” fit not providing much noticeable pressure without cinching it quite tight — which tracks with the mechanism this device is supposed to work through. Star-rating counts on this specific listing are modest, so treat the sentiment as directionally positive rather than statistically robust.
Here’s what actually justifies a Tier 1 label for this category, and it’s worth being precise about which study is doing the work. Most of the research on counterforce braces compares them to other treatments — physiotherapy, wrist splints, laser therapy — not to a true placebo. Only one trial tracked patients over weeks and months against a true placebo brace: a prospective, randomized, double-blinded, placebo-controlled trial comparing a counterforce brace to a non-therapeutic sham brace in patients with acute lateral epicondylitis (mean symptom duration 16 weeks[2]), analyzed as 17 patients in the brace group versus 14 in the placebo group[3]. (A separate placebo-controlled study exists — Sadeghi-Demneh & Jafarian 2013[6] — but it measured only the immediate, single-session effect of wearing different orthoses, not outcomes over a course of treatment, so it doesn’t speak to the same question.) The real brace produced a significantly greater reduction in the level of pain at rest at 2 weeks (P<.001) and in the frequency of pain at rest at 6 and 12 weeks (P<.05), plus significantly better patient-rated overall elbow function at 26 weeks (P=.041), than the sham brace[3]. Worth noting as a limitation: the trial recruited 45 patients (22 brace, 23 placebo) but lost a meaningful share to follow-up by 26 weeks, leaving the 17-vs-14 analyzed group — smaller than the trial was originally designed for, which is part of why this evidence, while real, isn’t the last word. The trial received no manufacturer or industry funding, and it was independently rated “good” quality in the subsequent meta-analysis’s risk-of-bias assessment[2]. Worth flagging: this trial’s participants had a mean age of 51 in both arms[2] — so the main longitudinal sham-controlled evidence for the brace working at all comes from a population that skews older, not younger. Keep that in mind when reading the next category, where the picture gets more complicated with age.
In practice, a more recent episode of lateral epicondylitis can be a different situation from a problem that has been recurring or present for a long time. When I see someone whose symptoms have only been present for a relatively short period, the clinical picture is often more straightforward than in a patient who has been dealing with the same elbow pain repeatedly or for months.
With longer-standing symptoms, rest alone may not be enough to move things forward, and rehabilitation can become increasingly relevant. This is also how I tend to frame braces in clinical practice: a counterforce strap may help some patients with symptom control, but I would not present it as a substitute for physiotherapy or a broader rehabilitation approach. If a patient wants to try a brace, I see it more as an adjunct that may make certain activities easier while the underlying problem is being addressed.
Best Tennis Elbow Brace for Younger Adults and Athletes (Under 45): Cho-Pat Original Tennis Elbow Strap
Cho-Pat Original Tennis Elbow Strap — listed here as a purchasable example of the counterforce-brace category relevant to the age-related evidence below, not because this product itself was tested in the relevant trials.
| Pros | Cons |
|---|---|
| Adjustable, one-size-fits-most design with a built-in “Targeted Pressure Pad” for focused compression | Comfort is a recurring complaint in older reviews of this product line — several reviewers report it needs to be tightened enough to leave marks or feel restrictive before it “does anything”; it’s unclear how much of that feedback reflects the current one-size design versus older, size-specific versions |
| Long track record under the Cho-Pat name; some long-term users report years of reliable use with earlier versions of this product | Amazon/marketplace ratings for this listing are mixed depending on size and source — not fetch-verified for the current live listing |
| Lightweight, breathable “SoftAction” material per the current manufacturer listing | Study: No trial has tested this specific product against physiotherapy or a placebo in an under-45 population — the evidence below applies to counterforce braces as a category, not to this brand |
| Study: Strap tension measurably changes wrist proprioception and pain threshold in lateral epicondylosis patients[1] — that study didn’t compare adjustable-strap designs against sleeve designs for tension control, and found no significant effect of tension on isokinetic wrist-extensor strength itself |
What buyers say about the Cho-Pat Original Tennis Elbow Strap: Sentiment here is genuinely mixed, and it’s worth being upfront about that rather than smoothing it over. Positive reviews (Amazon, Walmart, and the manufacturer’s own site) describe it as effective and durable, including from a professional musician managing tendon overuse who has repurchased it for years — though some of the available reviews appear to predate the current one-size-fits-most redesign, so it’s not certain they describe today’s exact product. Negative reviews cluster around a specific complaint: the strap has to be pulled fairly tight to work, and for some wearers that crosses into “uncomfortable” or “leaves marks.” That tradeoff shows up repeatedly enough to be worth flagging, though it isn’t based on a systematic count of all available reviews.
Now the evidence, and why this category exists at all. A 2020 systematic review and meta-analysis pooled 17 randomized trials (1,145 participants) comparing counterforce braces to other conservative treatments for lateral epicondylitis[2]. Across all studies, the brace showed no significant short-term pain advantage over physiotherapy overall (SMD −0.02, 95% CI −0.85 to 0.80). But an age subgroup analysis found something more specific — and it’s worth being exact about what kind of finding this is: the review grouped trials, not individual patients, by each trial’s participants’ mean age, so “≤45” and “>45” below describe which trials a study fell into, not a threshold that applies to any single person at 44 versus 46. Among the trials whose participants’ mean age was 45 or younger, the brace showed a moderate-to-large advantage over physiotherapy on short-term pain (SMD −0.86, 95% CI −2.45 to 0.72), based on 3 studies. The honest caveat has to come with the number: that confidence interval crosses zero, which means this result is not statistically significant — the point estimate looks meaningful, but the underlying data (3 small trials, I² = 92% heterogeneity) can’t rule out no effect at all. The authors themselves describe it as a finding “that should be considered with caution” given the limited number of trials per subgroup[2]. This is exactly the shape of evidence this article’s Tier 2 label exists for: a real, biologically plausible signal (the authors propose that younger patients’ better soft-tissue remodeling capacity may explain it) that isn’t yet strong enough to call proven — and it’s a signal about counterforce bracing as a category, not about the Cho-Pat product specifically, which wasn’t in any of these trials. It’s listed here as one real, purchasable example of the category this evidence applies to, not as the brace the evidence singled out.
One practical difference I sometimes notice between younger and older patients has less to do with the elbow itself and more to do with how they respond to the injury. In my clinical experience, some younger patients find it particularly difficult to reduce training, work, or other activities that keep provoking the symptoms. Older patients can certainly do the same, but I sometimes find that they are more willing to pace themselves and give the elbow time to settle — perhaps simply because they have more experience dealing with injuries and recovery.
That is a clinical impression rather than an age-based rule. Still, continuing to repeatedly aggravate an already painful elbow can make recovery more difficult, regardless of age. When I discuss treatment, I therefore pay attention not only to the brace or the rehabilitation plan, but also to whether the patient can realistically modify the activity that keeps provoking the symptoms.
Older Mean-Age Trial Subgroup — Why We’re Not Naming a Top Tennis Elbow Brace Pick Here
No single tennis elbow brace is singled out for this group, and it’s worth being precise about why. This isn’t a case of a trial finding the brace “doesn’t work” for older patients — no placebo-controlled trial has tested that comparison by age. What exists is comparative evidence pointing away from the brace as a default choice in this age group, and — importantly — the current physical therapy clinical practice guideline on this exact condition reaches a more measured conclusion than a flat “don’t use it.”
That guideline, published in 2022 in the Journal of Orthopaedic & Sports Physical Therapy on behalf of two APTA specialty academies (Orthopaedic, and Hand and Upper Extremity)[5], cites this article’s same meta-analysis findings directly and lands on two graded recommendations: clinicians cannot be given a recommendation either way on using a counterforce or wrist-support orthosis for intermediate- or long-term symptom relief, because the evidence is conflicting (Grade D) — but clinicians may use one during activity for immediate, in-the-moment improvement in pain and strength when symptoms are aggravated by activity (Grade F). Neither recommendation uses a 45-year cutoff. That’s a real, current, authoritative source, and it’s more cautious than a categorical “skip the brace,” which is why this section doesn’t push a product either way rather than picking one against the grain of that guidance.
In the same meta-analysis, the age subgroup analysis of counterforce brace versus wrist splint found a large advantage for the wrist splint in trials whose participants had a mean age over 45 (SMD 0.65, 95% CI 0.16 to 1.14, using the same effect-size thresholds the review itself applies) — and unlike the under-45 finding above, this confidence interval does not cross zero, so it’s a statistically significant result, not just a trend[2]. The same subgroup comparison against physiotherapy leaned the same direction (SMD 0.64 favoring physiotherapy, 95% CI −0.45 to 1.74) but didn’t reach statistical significance. Separately, and not tied to age at all, the meta-analysis’s pooled long-term follow-up estimate (12–52 weeks) leaned toward physiotherapy over the brace (SMD 1.17, 95% CI −0.00 to 2.34) — but that confidence interval sits right at the edge of zero, heterogeneity across the four underlying trials was very high (I² = 94.4%), and the review’s own authors describe this particular comparison as inconclusive given the small number of small trials, rather than a settled result. The proposed mechanism for the age effect is that counterforce bracing relies partly on neuromuscular and proprioceptive effects at the elbow, and since motor control measurably declines with age, the brace’s mode of action may simply have less to work with in older patients[2][4].
One thing worth separating out clearly: the meta-analysis’s “long-term follow-up” language describes how long a trial measured outcomes for — it says nothing about how long a patient’s symptoms had already lasted before starting treatment. Age, symptom duration at baseline, and follow-up length are three different variables, and only age was the basis for the subgroup findings above. So it would be a mistake to read this section as evidence against bracing for long-standing or chronic symptoms specifically — that’s a genuinely separate question the age subgroup analysis doesn’t answer. If anything, the most directly relevant study on chronic symptoms points the other way: a small 2024 randomized trial in women with chronic lateral elbow tendinopathy (mean symptom duration roughly 1.2–1.3 years) found that adding a counterforce brace to a physiotherapy program produced significantly better pain reduction and forearm muscle activity than adding kinesiotaping or physiotherapy alone[7]. That’s one small trial and shouldn’t be overweighted either, but it’s a reason not to fold “long-standing symptoms” into the over-45 category here.
One nuance worth keeping in view on the age question specifically: this pattern is specifically about pain. For grip strength, a secondary outcome in the same review, the picture doesn’t point the same direction — though the available data here is the overall pooled figure across all ages, not an over-45-specific subgroup. Pooled grip-strength data actually favored the brace over the wrist splint (SMD 0.37, 95% CI −0.12 to 0.86, not statistically significant) and showed only a small, non-significant edge for physiotherapy over the brace[2]. So the case for looking at alternatives in this age group is specifically about pain relief relative to other conservative options — not a blanket statement that the brace does nothing.
Overall evidence quality across every one of these comparisons was rated low to very low using GRADE criteria, with downgrades for small trials, high statistical heterogeneity, and — in some comparisons — suspected publication bias[2]. Given that, and given that the current physical therapy clinical practice guideline itself can’t make a firm recommendation either way for intermediate- or long-term use[5], the reasonable takeaway isn’t “never use a brace over 45” — it’s that a wrist splint or physiotherapy is worth discussing as an alternative starting point, alongside a brace rather than instead of one by default. Physiotherapy for tendinopathy in general typically isn’t passive rest — it tends to involve active approaches like progressive tendon loading and, in a more painful early phase, isometric exercise — though the exact mix of interventions used in the physiotherapy arms of these specific trials varied and wasn’t broken down in what’s cited here.
A note on how current this evidence is: the 2020 meta-analysis’s literature search ended in June 2019. Several smaller randomized trials comparing counterforce bracing to kinesio taping and/or corticosteroid injection have been published since then. A 2023 trial found no significant difference between counterforce bracing and kinesio taping over one month[8]. The 2024 chronic-symptoms trial cited above found bracing added to physiotherapy outperformed kinesiotaping added to physiotherapy. A 2025 three-arm trial found no overall superiority among counterforce bracing, kinesio taping, and corticosteroid injection[9]. Taken together, these don’t overturn the picture above so much as add more of the same mixed, small-trial evidence to it.
Tennis Elbow Braces Comparison Table
This table is a navigation aid to help you find the right section among the tennis elbow braces covered above — it is not a ranking of one product against another.
| Category | Who it’s for | Evidence tier | Example product |
|---|---|---|---|
| Short-term relief after diagnosis | Adults with acute lateral epicondylitis | Tier 1 — placebo-controlled trial (category-level; product and full age range not directly tested) | Mueller Hg80 Premium Tennis Elbow Support |
| Younger adults / athletes | Adults roughly in the age range studies show a possible signal for (trial-level ≤45 subgroup, not an individual cutoff) | Tier 2 — promising, not statistically significant | Cho-Pat Original Tennis Elbow Strap |
| Older mean-age trial subgroup | Adults in trials with an older (>45) mean age | Low-certainty comparative subgroup evidence favors wrist splinting; the 2022 clinical practice guideline itself stays neutral on intermediate/long-term orthosis use | No pick singled out — a wrist splint or physiotherapy is worth discussing as an alternative starting point |
Tennis Elbow Braces FAQ
Does a tennis elbow brace actually work, or is it placebo? The main trial that tracked patients over weeks against a true placebo brace found a real, statistically significant difference in favor of the real brace, both for short-term pain and for 26-week function[3] — though notably, that trial’s own primary outcome measure (frequency of pain with activity at 26 weeks) wasn’t among the differences that reached significance; the significant results were on other pain and function measures. So “pure placebo” isn’t an accurate description of the best available evidence — but that trial analyzed only 31 patients (17 vs. 14), and most of the other comparisons in this article pit the brace against an active treatment (physiotherapy, wrist splint) rather than a sham.
What did the age subgroup analysis actually find? It’s a hypothesis-generating finding from low-certainty, trial-level data grouped by participants’ mean age — not a validated clinical cutoff. The under-45 signal (favoring bracing over physiotherapy) wasn’t statistically significant; the older mean-age signal (favoring wrist splinting over bracing) was. Worth factoring in, but not worth treating as a settled rule for any one person at a specific age. Separately: this is about age, not about how long someone has had symptoms — the limited evidence specifically on longer-standing (chronic) tennis elbow doesn’t point in the same “avoid the brace” direction[2][7].
How tight should the strap be? The available research doesn’t establish an optimal tightness for everyday wear — a single lab study found strap tension changed wrist proprioception and pain threshold to passive stretching in a one-off session[1], but didn’t test what happens with prolonged daily use or identify a “right” level of tension. Some reviews describe a comfort-versus-tension tradeoff for at least one product here, so this is worth working out by feel rather than chasing a specific number. [CLINICAL NOTE]
Should I use a compression sleeve instead of a strap? This article focuses on counterforce devices — designs that apply focal pressure below the elbow, whether in strap or sleeve form — because that’s what the cited research tested, including a counterforce sleeve. Generic, fully elastic compression sleeves with no focal counterforce element weren’t evaluated in the evidence reviewed here.
When should I see a doctor instead of just trying a brace? As general clinical guidance rather than something drawn from the studies above: if pain doesn’t meaningfully improve after several weeks of conservative measures, or if you have significant weakness, numbness, or night pain, that’s a reason to get an in-person evaluation rather than continuing to self-manage.
What This Means for Buyers Choosing a Tennis Elbow Brace
- Acute symptoms: The counterforce-brace category has the best-quality evidence behind it — a real placebo-controlled trial showing benefit in adults with acute lateral epicondylitis (not tested across every age group, and not this specific product) — so a brace like the Mueller Hg80 is a reasonable first thing to try.
- Under 45: One meta-analysis subgroup found a possible edge for counterforce bracing as a category over physiotherapy in trials whose participants’ mean age was 45 or younger — but that finding didn’t reach statistical significance, and it doesn’t identify Cho-Pat or any specific product as superior. Treat it as “worth trying the category,” not “this brand is proven better.”
- Older mean-age trial subgroup: Don’t assume a brace is the obvious first move. Some low-certainty comparative subgroup data favor alternatives, particularly wrist splinting — worth raising with a physiotherapist or physician. (The 2022 clinical practice guideline itself doesn’t take a side here; it stays neutral on intermediate- and long-term orthosis use rather than pointing toward wrist splinting or physiotherapy specifically.) This is separate from how long symptoms have lasted — the limited evidence on chronic symptoms specifically doesn’t point away from bracing.
Overall, a counterforce brace can be helpful for some patients with tennis elbow, but I would not view it as a substitute for rehabilitation. In practice, early management often focuses on reducing aggravating activity and controlling symptoms, and a short course of an NSAID may sometimes be considered when appropriate. Physiotherapy then becomes an important part of the broader treatment approach, particularly if symptoms persist.
A brace can be added when needed, especially if it makes work or exercise more tolerable, but I would be cautious about relying on it alone. In my clinical experience, some younger patients seem to find these braces particularly useful because they are often keen to stay active rather than completely back off from training or work. Even then, the brace is best thought of as a supportive tool rather than the treatment itself.
References
- https://pubmed.ncbi.nlm.nih.gov/15029940/
- https://journals.sagepub.com/doi/10.1177/0309364620930618
- https://pubmed.ncbi.nlm.nih.gov/30658774/
- https://pubmed.ncbi.nlm.nih.gov/19850077/
- https://www.jospt.org/doi/10.2519/jospt.2022.0302
- https://pubmed.ncbi.nlm.nih.gov/24349776/
- https://journals.sagepub.com/doi/10.1177/22104917231208211
- https://pubmed.ncbi.nlm.nih.gov/37949566/
- https://pubmed.ncbi.nlm.nih.gov/40680057/
